Clinical Trials Directory

Trials / Completed

CompletedNCT00949741

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

Observational Retrospective Multicenter Study for the Citofluorimetric Analysis of Cerebrospinal Fluid Vs Conventional Method in Patients With Aggressive Non-Hodgkin's Lymphoma Without Leptomeningeal Disease

Status
Completed
Phase
Study type
Observational
Enrollment
175 (actual)
Sponsor
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to define if flow cytometry has more sensitivity for detecting neoplastic cells in cerebrospinal fluid versus conventional cytology.

Detailed description

Aggressive B-cell non-Hodgkin's lymphoma (B-NHL), Lymphoblastic Lymphoma and Burkitt's Lymphoma are at high risk of CNS relapse. For this reason is recommended a prophylaxis therapy. This suggests that negative leptomeningeal localization patients at diagnosis are really positive and that would be a very high risk of CNS relapse subtype patients. It's very important detecting neoplastic cells in cerebrospinal fluid as soon as possible. This study will evaluate only patients that have been flow cytometry and cytology at diagnosis.

Conditions

Timeline

Start date
2009-07-01
Primary completion
2011-10-01
Completion
2012-10-01
First posted
2009-07-30
Last updated
2013-10-22

Locations

12 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT00949741. Inclusion in this directory is not an endorsement.